酮康唑市場：現況分析與預測（2023-2030）

Ketoconazole Market: Current Analysis and Forecast (2023-2030)

出版日期: 2023年12月30日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 151 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

由於合作夥伴關係和收購的增加，酮康唑市場預計在預測期內將以 3.1% 的複合年增長率強勁增長。例如，2020 年 9 月，Alliance 與 Alniche 獨家合作，在印度銷售 Nizral &Nizoral（酮康唑，以 Nizoral 品牌銷售）。其他幾個因素也促進了市場的快速擴張，包括產品推出數量的增加、食品和製藥行業酮康唑使用量的增加、人口增長、護膚品需求的快速增長、企業合作夥伴關係和產品發射。例如，2020 年 11 月，山德士與 Civica Rx 合作，向美國醫院運送了首款藥物泮托拉唑。

依產品類型，市場分為酮康唑口服製劑、酮康唑外用製劑及酮康唑洗髮精。由於其易於表面應用，外用酮康唑細分市場在 2022 年佔據最高市場份額。本品用於治療各種類型的真菌性皮膚感染，也可預防復發。此外，外用製劑的生產更容易、更便宜，使其在市場上更具競爭力。製造商努力改善其產品的用戶體驗並使其更易於使用。因此，酮康唑外用細分市場在 2022 年將佔據重要市場份額。

依應用，市場分為抗真菌、除毛等。由於脫髮病例數量不斷增加，預計除毛領域在預測期內將以最高複合年增長率增長。此外，對護髮藥物不斷增長的需求、對安全藥物替代品的需求、策略聯盟和合作研究以及創新產品的推出都進一步推動了對智慧產品的需求。因此，預計脫毛領域將在預測期內在市場上佔據主導地位。

為了更了解酮康唑產業的市場實施情況，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、義大利、歐洲其他地區）、亞太地區（中國、日本、印度、亞太地區其他地區）及世界其他國家。 2022年酮康唑市場由北美主導。尖端和創新產品的可用性、人們對健康問題的認識不斷提高以及該地區不斷增長的城市人口正在推動對這些抗真菌藥物的需求以及對酮康唑產品開發的投資。有幾個因素正在推動該地區的市場，包括：按地區劃分，2022 年北美將主導酮康唑市場。

Ketoconazole is an antifungal medication used to treat various fungal infections like athlete's foot, ringworm, and yeast infections. It's available in different forms like shampoo, cream, and oral tablets. It works by inhibiting the growth of fungi. However, it's essential to use it as prescribed by a healthcare professional due to potential side effects and interactions with other medications. The ketoconazole market is growing at a tremendous rate owing to the higher cases of skin problems. Other factors such as the increased utilization of ketoconazole in the healthcare industry due to the rise in fungal infections, the growing awareness among consumers regarding health concerns, and a rise in the urban population are driving factors for the market.

The Ketoconazole Market is expected to grow at a strong CAGR of 3.1% during the forecast period owing to the rising partnerships and acquisitions. For instance, in September 2020, Alliance exclusively partnered with Alniche to market Nizral & Nizoral (Ketoconazole, sold under the brand name Nizoral) in India. Several other factors such as an increased number of product launches, increased usage of ketoconazole in the food and pharma industry, rising population, upsurge in demand for skincare products, company collaborations, and product launches are also leading to the surge in the market. For instance, in November 2020, Sandoz shipped its first medicine Pantoprazole in collaboration with Civica Rx to supply US hospitals.

Based on product type, the market is segmented into ketoconazole oral, ketoconazole topical, and ketoconazole shampoo. The ketoconazole topical segment held the highest share of the market in the year 2022 owing to the ease of applying it on the surface. It is used to treat skin infections caused by different types of fungus and can also prevent them from coming back. Also, manufacturing topical form is easier and less expensive, which provides competitive pricing to the segment in the market. Manufacturers strive to improve their product's user experience to make it more accessible. Hence, the ketoconazole topical segment held a significant share of the market in the year 2022.

Based on application, the market is segmented into antifungal, hair loss, and others. The hair loss segment is expected to grow with the highest CAGR during the forecast period owing to rising cases of hair loss. Also, the rising demand for haircare medicines, the need for safe options for medicines, strategic collaborations and collaborations, and innovative product launches have further increased the demand for intelligent products. Thus, the hair loss segment is expected to gain prominence in the market in the forecast period.

For a better understanding of the market adoption of the ketoconazole industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America dominated the market of ketoconazoles in 2022. Several factors such as the availability of cutting-edge and innovative products, growing awareness about health concerns, the rising urban population in the region are increasing the demand for such antifungal drugs, and loaded investment in ketoconazole product discovery are driving the market in the region. North America dominated the ketoconazole market among regions in the year 2022.

Some of the major players operating in the market include: Mylan Inc.; Almirall, S.A; Johnson & Johnson Services, Inc.; Taro Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd.; Sandoz Group AG; Strides Pharma Science Limited; LGM Pharma; AKSHAR PHARMA; Gonane Pharma.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Ketoconazole Market
2.2. Research Methodology of the Ketoconazole Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE KETOCONAZOLE MARKET

6 KETOCONAZOLE MARKET REVENUE (USD BN), 2020-2030F

7 MARKET INSIGHTS BY PRODUCT TYPE

7.1. Ketoconazole Oral
7.2. Ketoconazole Topical
7.3. Ketoconazole Shampoo

8 MARKET INSIGHTS BY APPLICATION

8.1. Antifungal
8.2. Hair Loss
8.3. Others

9 MARKET INSIGHTS BY REGION

9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Rest of North America
9.2. Europe
- 9.2.1. Germany
- 9.2.2. U.K.
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Rest of Asia-Pacific
9.4. Rest of World